Candida peritonitis complicating peritoneal dialysis: successful treatment with low dose amphotericin B therapy.
Two patients undergoing peritoneal dialysis with permanent indwelling peritoneal catheters who developed Candida albicans peritonitis are presented. Both patients were successfully treated with low dose intravenous amphotericin B. Sequential candida precipitin assays were performed and the diagnostic application is discussed.
D058186:Acute Kidney Injury / Q000628:therapy; D000328:Adult; D000368:Aged; D000666:Amphotericin B / Q000008:administration & dosage*; D000908:Antibodies, Fungal / Q000032:analysis; D002177:Candidiasis / Q000188:drug therapy* / Q000276:immunology; D002408:Catheters, Indwelling; D004305:Dose-Response Relationship, Drug; D004352:Drug Resistance, Microbial; D006801:Humans; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000188:drug therapy* / Q000276:immunology / Q000382:microbiology; D013530:Surgical Wound Infection / Q000188:drug therapy
D000908:Antibodies, Fungal; D000666:Amphotericin B